Clinical Trial Update: Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing CNV2197944 to placebo in patients with Diabetic Peripheral Neuropathy has completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• CNV2197944

Snippet

Sponsor: Convergence Pharmaceuticals | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED